IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 24 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,059 | -38.2% | 26,808 | 0.0% | 0.02% | -34.4% |
| Q2 2023 | $79,352 | +6.9% | 26,808 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $74,258 | -46.8% | 26,808 | 0.0% | 0.03% | -49.2% |
| Q4 2022 | $139,670 | +30.5% | 26,808 | 0.0% | 0.06% | +23.5% |
| Q3 2022 | $107,000 | +40.8% | 26,808 | +34.0% | 0.05% | +41.7% |
| Q2 2022 | $76,000 | -26.2% | 20,000 | 0.0% | 0.04% | -18.2% |
| Q1 2022 | $103,000 | -3.7% | 20,000 | 0.0% | 0.04% | -2.2% |
| Q4 2021 | $107,000 | -20.7% | 20,000 | -7.9% | 0.04% | -27.4% |
| Q3 2021 | $135,000 | +3.1% | 21,718 | 0.0% | 0.06% | +1.6% |
| Q2 2021 | $131,000 | -38.5% | 21,718 | 0.0% | 0.06% | -46.0% |
| Q1 2021 | $213,000 | -34.5% | 21,718 | 0.0% | 0.11% | -38.9% |
| Q4 2020 | $325,000 | – | 21,718 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 396,425 | $5,927,000 | 0.29% |
| Gradient Capital Advisors, LLC | 21,718 | $325,000 | 0.18% |
| Hillsdale Investment Management Inc. | 15,200 | $232,000 | 0.02% |
| Orion Portfolio Solutions, LLC | 15,821 | $237,000 | 0.01% |
| IFP Advisors, Inc | 1,960 | $30,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 300 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 7 | $0 | 0.00% |
| MORGAN STANLEY | 2,100 | $31,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,900 | $98,000 | 0.00% |